ID

18206

Description

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00287872

Link

https://clinicaltrials.gov/show/NCT00287872

Keywords

Versions (1)
  1. 10/25/16 10/25/16 -
Uploaded on

October 25, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00287872

English

Eligibility Multiple Myeloma NCT00287872

1 forms  
Criteria
Description

Criteria

newly diagnosed salmon-durie stage ii or iii multiple myeloma
Description

Multiple Myeloma | Staging

Data type

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2]
C0332305
untreated disease or patient underwent prior therapy for this cancer that lasted no more than 2 weeks
Description

Disease untreated | Prior Therapy Multiple Myeloma

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0026764
measurable paraprotein in serum or urine (serum free-lite assay measurement allowed)
Description

Serum paraprotein measurement | Urine paraprotein measurement

Data type

boolean

Alias
UMLS CUI [1]
C0585639
UMLS CUI [2]
C0585640
no evidence of cord compression requiring concurrent steroids
Description

Compression of spinal cord Evidence Requirement Steroids

Data type

boolean

Alias
UMLS CUI [1,1]
C0037926
UMLS CUI [1,2]
C3887511
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0038317
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
creatinine clearance ≥ 30 ml/min
Description

Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0373595
not pregnant or nursing
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
negative pregnancy test
Description

Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use 2 methods of contraception, including ≥ 1 highly effective method, 4 weeks before, during, and for ≥ 4 weeks after completion of study treatment
Description

Fertility Contraceptive methods Quantity | Fertility Contraceptive methods Effective Highly Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0015895
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C1280519
UMLS CUI [2,4]
C0205250
UMLS CUI [2,5]
C1265611
no known hiv positivity
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
no peripheral neuropathy ≥ grade 2
Description

Peripheral Neuropathy | CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
no hypersensitivity to bortezomib, boron, or mannitol
Description

Hypersensitivity bortezomib | Hypersensitivity Boron | Mannitol allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1176309
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0006030
UMLS CUI [3]
C0571922
prior concurrent therapy:
Description

Prior Therapy

Data type

boolean

Alias
UMLS CUI [1]
C1514463
no prior bortezomib
Description

bortezomib

Data type

boolean

Alias
UMLS CUI [1]
C1176309
more than 28 days since prior regimens with a duration of > 1 week but ≤ 2 weeks
Description

Regimen Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0040808
UMLS CUI [1,2]
C0449238
no steroids within 14 days prior to study entry
Description

Steroids

Data type

boolean

Alias
UMLS CUI [1]
C0038317
no concurrent corticosteroids except for the treatment of a nonmalignant condition
Description

Adrenal Cortex Hormones | Therapeutic procedure Nonmalignant Conditions

Data type

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0032927
may not exceed the equivalent dose of prednisone 10 mg/day
Description

Prednisone Dosage Equivalent

Data type

boolean

Alias
UMLS CUI [1,1]
C0032952
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205163
no concurrent chemotherapy, immunotherapy, radiotherapy, or surgery
Description

Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Operative Surgical Procedures

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0543467
no other concurrent investigational agents
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00287872

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Multiple Myeloma | Staging
Item
newly diagnosed salmon-durie stage ii or iii multiple myeloma
boolean
C0026764 (UMLS CUI [1])
C0332305 (UMLS CUI [2])
Disease untreated | Prior Therapy Multiple Myeloma
Item
untreated disease or patient underwent prior therapy for this cancer that lasted no more than 2 weeks
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0026764 (UMLS CUI [2,2])
Serum paraprotein measurement | Urine paraprotein measurement
Item
measurable paraprotein in serum or urine (serum free-lite assay measurement allowed)
boolean
C0585639 (UMLS CUI [1])
C0585640 (UMLS CUI [2])
Compression of spinal cord Evidence Requirement Steroids
Item
no evidence of cord compression requiring concurrent steroids
boolean
C0037926 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0038317 (UMLS CUI [1,4])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Creatinine clearance measurement
Item
creatinine clearance ≥ 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods Quantity | Fertility Contraceptive methods Effective Highly Quantity
Item
fertile patients must use 2 methods of contraception, including ≥ 1 highly effective method, 4 weeks before, during, and for ≥ 4 weeks after completion of study treatment
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0015895 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1280519 (UMLS CUI [2,3])
C0205250 (UMLS CUI [2,4])
C1265611 (UMLS CUI [2,5])
HIV Seropositivity
Item
no known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Peripheral Neuropathy | CTCAE Grades
Item
no peripheral neuropathy ≥ grade 2
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Hypersensitivity bortezomib | Hypersensitivity Boron | Mannitol allergy
Item
no hypersensitivity to bortezomib, boron, or mannitol
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
Prior Therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
bortezomib
Item
no prior bortezomib
boolean
C1176309 (UMLS CUI [1])
Regimen Duration
Item
more than 28 days since prior regimens with a duration of > 1 week but ≤ 2 weeks
boolean
C0040808 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Steroids
Item
no steroids within 14 days prior to study entry
boolean
C0038317 (UMLS CUI [1])
Adrenal Cortex Hormones | Therapeutic procedure Nonmalignant Conditions
Item
no concurrent corticosteroids except for the treatment of a nonmalignant condition
boolean
C0001617 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0032927 (UMLS CUI [2,2])
Prednisone Dosage Equivalent
Item
may not exceed the equivalent dose of prednisone 10 mg/day
boolean
C0032952 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205163 (UMLS CUI [1,3])
Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Operative Surgical Procedures
Item
no concurrent chemotherapy, immunotherapy, radiotherapy, or surgery
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0543467 (UMLS CUI [4])
Investigational New Drugs
Item
no other concurrent investigational agents
boolean
C0013230 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial